An Update on Anti-Amyloid Treatments for Alzheimer's Disease

Поделиться
HTML-код
  • Опубликовано: 17 окт 2024
  • Drs. Jason Karlawish and David Wolk discuss lecanemab (Leqembi), donanemab, and the impact these medications will have on Penn Memory Center patients and research participants.

Комментарии • 1